*The following content is generated by AI and is for reference only.
Overview
Daclatasvir is a direct-acting antiviral agent targeting the HCV NS5A protein. Synthesized via complex organic coupling, its molecular formula is C29H27ClN4O2 (CAS: 1080506-36-2).
Application
- Pharmaceutical Manufacturing: Bulk API production for combination therapies.
- Viral Treatment: Chronic Hepatitis C infection management.
- R&D: Clinical trial supply for novel antiviral formulations.
Precautions
Strictly store below 25°C in dry conditions. Use only under medical supervision; contraindicated with strong CYP3A inducers. Ensure PPE compliance during handling to prevent inhalation risks.